In vitro experiments showed that knockdown of IL-1β significantly inhibited cell proliferation, migration, and invasion, while overexpression of IL-1β exhibited the opposite effect, indicating the role of IL-1β as a tumor promoter in ESCC. Here, IL1B is linked to esophageal squamous cell carcinoma.